Analyst Price Targets — ZTS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 26, 2026 11:08 am | Mark Massaro | BTIG | $160.00 | $128.95 | StreetInsider | BTIG Reiterates Buy Rating on Zoetis Inc. (ZTS) |
| January 29, 2026 2:22 pm | — | UBS | $136.00 | $122.75 | TheFly | Zoetis price target lowered to $136 from $141 at UBS |
| January 22, 2026 8:42 am | David Westenberg | Piper Sandler | $135.00 | $125.08 | StreetInsider | Piper Sandler Downgrades Zoetis Inc. (ZTS) to Neutral |
| December 18, 2025 12:56 pm | — | Morgan Stanley | $160.00 | $124.54 | TheFly | Zoetis price target lowered to $160 from $175 at Morgan Stanley |
| December 10, 2025 11:18 am | — | HSBC | $140.00 | $115.75 | TheFly | Zoetis price target lowered to $140 from $180 at HSBC |
| December 8, 2025 9:28 pm | — | Barclays | $136.00 | $118.16 | TheFly | Zoetis initiated with an Equal Weight at Barclays |
| November 4, 2025 6:05 pm | — | Stifel Nicolaus | $140.00 | $125.50 | TheFly | Zoetis price target lowered to $140 from $155 at Stifel |
| October 20, 2025 1:36 pm | — | UBS | $158.00 | $144.90 | TheFly | Zoetis price target lowered to $158 from $165 at UBS |
| August 11, 2025 10:29 am | David Westenberg | Piper Sandler | $215.00 | $148.86 | TheFly | Zoetis price target raised to $215 from $210 at Piper Sandler |
| June 17, 2025 10:44 pm | Jonathan Block | Stifel Nicolaus | $160.00 | $161.67 | TheFly | Zoetis downgraded to Hold from Buy at Stifel |
Latest News for ZTS
Bahl and Gaynor Inc. trimmed its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 91.8% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 16,870 shares of the company's stock after selling 189,941 shares during the quarter.
Elo Mutual Pension Insurance Co increased its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 37.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 44,185 shares of the company's stock after purchasing an additional 12,032 shares
111 Capital trimmed its holdings in shares of Zoetis Inc. (NYSE: ZTS) by 74.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,692 shares of the company's stock after selling 19,322 shares during the period. 111 Capital's holdings in Zoetis were worth
US equity markets posted positive returns once again in Q4, although the small and large portions of the market were stronger performers, returning 2.19% and 2.41%, respectively. Recently, we have found stocks with a little less debt and less cyclicality more appealing. We exited our position in Civitas Resources, Lear Corp., Check Point Software Technologies and Marzetti.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to acquire animal genomics business from Neogen, strengthening the company's leadership in Precision Animal Health.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.